
|Articles|December 1, 2016
- Pharmaceutical Executive-12-01-2016
- Volume 36
- Issue 12
Pharmaceutical Executive, December 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive December 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Medical Game-Changers Beckonover 9 years ago
Investing in Africa: How to Do It Rightover 9 years ago
The Winning Edge in Emerging Marketsover 9 years ago
Paula Apsell: A Storied Life in Scienceover 9 years ago
Going to the Edgeover 9 years ago
Trump Administration Offers Relief, and Challenges, for Pharmaover 9 years ago
Executive Pay and Innovationover 9 years ago
Science: The Communal Languageover 9 years ago
Will NICE ‘Go Commercial’?over 9 years ago
Country Report: MexicoAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Taking a Hard Look at Pharma's Traditional Margin Model
2
Modern Policy Concerns Stemming from 340B
3
Funding Roundup: Silence Therapeutics, AbCellera Announce IPO Pricing, Beyang, Remepy Close Series A Financing
4
Pharmaceutical Executive Daily: Mereo BioPharma Enters Option and License Agreement with Sentynl Therapeutics
5



